|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||95.32 / 113.90|
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.
Blueprint unveiled new data from its ongoing Phase 1 study of avapritinib in advanced systemic mastocytosis at the 59th American Society of Hematology Annual Meeting.
Apple (AAPL) shares bucked the upward trend in tech stocks after Citigroup analysts cut iPhone sales estimates on Monday.